Risk-adapted treatment of acute promyelocytic leukemia: Updated results of the Spanish PETHEMA LPA99 Trial using ATRA and anthracycline monochemotherapy.

被引：0
|
作者：
Sanz, MA
Martin, G
Vellenga, E
Bolufer, P
Gonzalez, M
Rayon, C
de la Serna, J
Parody, R
Bergua, J
Negri, S
Rivas, C
机构：
[1] PETHEMA Grp, Valencia, Spain
[2] HOVON Grp, Valencia, Spain
[3] GATLA Grp, Valencia, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：563S / 563S
页数：1
相关论文
共 31 条
  • [1] Risk-adapted treatment of acute promyeliacytic leukemia: Updated results of the Spanish PETHEMA LPA99 trial using ATRA and anthracycline monochemotherapy
    Sanz, Miguel A.
    Montesinos, Pau
    Vellenga, Edo
    Rayon, Chelo
    Parody, Ricardo
    De la Serna, Javier
    Bergua, Juan
    Leon, Angel
    Negri, Silvia
    Rivas, Concha
    Brunet, Salut
    Gonzalez, Marcos
    Esteve, Jordi
    Lowenberg, Bob
    [J]. BLOOD, 2007, 110 (11) : 182A - 182A
  • [2] Risk-adapted treatment of acute promyelocytic leukemia:: Results of the Spanish PETHEMA trials using ATRA and anthracycline-based chemotherapy.
    Sanz, MA
    Martín, G
    Barragán, E
    Rayón, C
    Capote, FJ
    Novo, A
    Escoda, L
    Bergua, JM
    Alvarez, C
    León, A
    de la Serna, J
    Esteve, J
    Galán, C
    Rodríguez, A
    Debén, G
    Pérez, M
    Figuera, A
    Bolufer, P
    González, M
    Colomer, D
    Gómez, T
    Román, J
    Calasanz, MJ
    [J]. BLOOD, 2001, 98 (11) : 765A - 765A
  • [3] Risk-adapted treatment of acute promyelocytic leukemia with all-trans retinoic acid and anthracycline monochemotherapy:: long-term outcome of the LPA 99 multicenter study by the PETHEMA Group
    Sanz, Miguel A.
    Montesinos, Pau
    Vellenga, Edo
    Rayon, Consuelo
    de la Serna, Javier
    Parody, Ricardo
    Bergua, Juan M.
    Leon, Angel
    Negri, Silvia
    Gonzalez, Marcos
    Rivas, Concha
    Esteve, Jordi
    Milone, Gustavo
    Gonzalez, Jose D.
    Amutio, Elena
    Brunet, Salut
    Garcia-Larana, J.
    Colomer, Dolors
    Calasanz, Maria J.
    Chillon, Carmen
    Barragan, Eva
    Bolufer, Pascual
    Lowenberg, Bob
    [J]. BLOOD, 2008, 112 (08) : 3130 - 3134
  • [4] Risk-adapted treatment of acute promyelocytic leukemia with all-trans-retinoic acid and anthracycline monochemotherapy:: a multicenter study by the PETHEMA group
    Sanz, MA
    Martín, G
    González, M
    León, A
    Rayón, C
    Rivas, C
    Colomer, D
    Amutio, E
    Capote, FJ
    Milone, GA
    de la Serna, J
    Román, J
    Barragán, E
    Bergua, J
    Escoda, L
    Parody, R
    Negri, S
    Calasanz, MJ
    Bolufer, P
    [J]. BLOOD, 2004, 103 (04) : 1237 - 1243
  • [5] Risk-Adapted Treatment of Acute Promyelocytic Leukemia: Results of the PETHEMA LPA2005 Trial Using All-Trans Retinoic Acid and Anthracycline with Cytarabine for High-Risk Patients
    Sanz, Miguel A.
    Montesinos, Pau
    Holowiecka, Aleksandra
    Milone, Gustavo
    Rayon, Chelo
    de Lisa, Elena
    de la Sema, Javier
    Brunet, Salut
    Leon, Angel
    Krsnik, Isabel
    Rivas, Concha
    Ribera, Jose M.
    Gonzalez, Jose
    Diaz-Mediavilla, Joaquin
    Bueno, Javier
    David Gonzalez, Jose
    Bergua, Juan
    Gonzalez, Marcos
    [J]. BLOOD, 2008, 112 (11) : 57 - 57
  • [6] Risk-adapted treatment of acute promyelocytic leukemia with AIDA derived regimens: The Pethema experience
    Sanz, M. A.
    [J]. ANNALS OF HEMATOLOGY, 2006, 85 : 98 - 99
  • [7] Risk-adapted treatment of acute promyelocytic leukemia with AIDA derived regimens: The PETHEMA experience
    Sanz, M. A.
    [J]. ANNALS OF HEMATOLOGY, 2008, 87 : S80 - S81
  • [8] TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA WITH PETHEMA LPA 99 TRIAL: TUNISIAN SINGLE CENTER EXPERIENCE
    Jeddi, R.
    Benneji, H.
    Kacem, K.
    Mnif, S.
    Ben Amor, R.
    Aissaoui, L.
    Ben Lakhal, R.
    Benabid, H.
    Belhadjali, Z.
    Meddeb, B.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 456 - 456
  • [9] Risk-adapted Treatment of Acute Promyelocytic Leukemia with all-trans-retinoic Acid and Anthracycline Mono Chemotherapy : A Multicenter Study by the PETHEMA Group
    Sanz, Miguel A.
    Martin, Guillermo
    Gonzalez, Marcos
    Leon, Angel
    Rayon, Chelo
    Rivas, Concha
    Colomer, Dolors
    Amutio, Elena
    Capote, Francisco J.
    Milone, Gustavo A.
    De la Serna, Javier
    Roman, Jose
    Barragan, Eva
    Bergua, Juan
    Escoda, Lourdes
    Parody, Ricardo
    Negri, Silvia
    Calasanz, Maria J.
    Bolufer, Pascual
    [J]. INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2005, 26 (01) : 41 - 42
  • [10] All-trans retinoic acid and anthracycline reinforcement in consolidation improve the outcome of patients with intermediate and high-risk acute promyelocytic leukemia:: Results of the Spanish PETHEMA trial LPA99.
    Sanz, MA
    Martín, G
    Barragán, E
    Rayón, C
    Debén, G
    Rivas, C
    Esteve, J
    Díaz-Mediavilla, J
    De la Serna, J
    Amutio, E
    León, A
    González, M
    Tormo, M
    Novo, A
    Capote, FJ
    Bergua, JM
    González, J
    Bolufer, P
    Colomer, D
    Gómez, T
    Román, J
    Calasanz, MJ
    [J]. BLOOD, 2002, 100 (11) : 155A - 156A
1234